Litcius/Paper detail

Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial

Hidenori Yaku, Takao Kato, Takeshi Morimoto, Kazuhisa Kaneda, Ryusuke Nishikawa, Takeshi Kitai, Yasutaka Inuzuka, Yodo Tamaki, Taketoshi Yamazaki, Jun Kitamura, Hirotaka Ezaki, Kazuya Nagao, Hiromi Yamamoto, Akihiro Isotani, Takeshi Arita, Chisato Izumi, Yukihito Sato, Yoshihisa Nakagawa, Satoaki Matoba, Yasushi Sakata, Koichiro Kuwahara, Takeshi Kimura

2023American Heart Journal21 citationsDOI

Topics & Concepts

MedicineRandomized controlled trialHeart failureClinical endpointRegimenAdverse effectVolume overloadClinical trialIntensive care medicineDiureticFurosemideLoop diureticInternal medicineHeart Failure Treatment and ManagementElectrolyte and hormonal disordersIon Transport and Channel Regulation
Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial | Litcius